Gaudium IVF and Women Health Limited is a specialized fertility and women’s healthcare provider that delivers Assisted Reproductive Technology (ART) services across India. The Company primarily focuses on In Vitro Fertilization (IVF) treatments and comprehensive reproductive healthcare solutions for both male and female infertility.
The Company operates through a hub-and-spoke model, enabling operational efficiency and wider patient outreach.
- 30+ operational locations
- 7 Hubs (full-fledged IVF centres)
- 28 Spokes (partnered or affiliated centres)
The hub centres are equipped with advanced embryology labs and infrastructure required for complex ART procedures, while the spokes focus on consultations, diagnostics, and patient engagement before referring cases to hub centres for advanced treatment.
The Company also serves patients from Canada, the UK, the US, Kenya, South Africa, and Oman, highlighting its presence in medical tourism and cross-border fertility care.
The Company operates centres in major cities, including Delhi (Janakpuri and Kailash Colony), Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, providing strategic presence across North, West, and South India.
The Company provides fertility treatments, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction to address various male and female infertility challenges.
The Company also provides gynecological care, including management of PCOD/PCOS, endometriosis treatment, and support for high-risk pregnancies.
The Company provides advanced sperm retrieval and diagnostic services for male infertility management.
Gaudium IVF IPO – Details
| IPO Opening Date | 20 February 2026 |
| IPO Closing Date | 24 February 2026 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 2,08,86,200 Shares Worth ₹165 Crore Fresh Issue: 1,13,92,500 Shares Worth ₹90 Crore Offer For Sale: 94,93,700 Shares Worth ₹75 Crore |
| Face Value | ₹5 per equity share |
| IPO Price | ₹75 – ₹79 per share |
| Market Lot | 189 Shares |
| Min Order | 189 Shares [ 1 Lot ] |
| Listing At | BSE, NSE |
| Register | Bigshare Services Pvt. Ltd. |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Gaudium IVF IPO – Date Schedule
| IPO Open Date | 20 February 2026 |
| IPO Close Date | 24 February 2026 |
| Basis of Allotment | 25 February 2026 |
| Initiation of Refund | 26 February 2026 |
| Credit of Shares to Demat Account | 26 February 2026 |
| IPO Listing Date | 27 February 2026 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 24, 2026 |
Gaudium IVF IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 189 | ₹14,931 |
| Retail (Max) | 13 | 2,457 | ₹1,94,103 |
| S-HNI (Min) | 14 | 2,646 | ₹2,09,034 |
| S-HNI (Max) | 66 | 12,474 | ₹9,85,446 |
| B-HNI (Min) | 67 | 12,663 | ₹10,00,377 |
Competitive Strength
- Patient-Centric Approach.
- Expert team.
- Using next-gen INTEGRA Ti labs for ICSI.
- Highly Technical USG Guided Services.
- Established central hubs in prime urban locations, including Mumbai, Bangalore, Delhi NCR, and Patna.
- Asset Light Business Model.
Company Promoters
- Dr. Manika Khanna
- Dr. Peeyush Khanna
- Vishad Khanna
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2023 | ₹44.26 Cr | ₹25.95 Cr | ₹13.53 Cr | ₹9.78 Cr |
| 31 March 2024 | ₹48.15 Cr | ₹31.52 Cr | ₹10.32 Cr | ₹15.73 Cr |
| 31 March 2025 | ₹70.96 Cr | ₹45.54 Cr | ₹19.13 Cr | ₹18.93 Cr |
| 30 September 2025 | ₹49.75 Cr | ₹32.97 Cr | ₹12.51 Cr | ₹22.51 Cr |
Key Performance Indicator
| KPI | Values (Sep 30, 2025) |
|---|---|
| ROE | 21.25% |
| ROCE | 21.03% |
| Debt/Equity | 0.38 |
| RoNW | 21.34% |
| PAT Margin | 25.14% |
| EBITDA Margin | 38.29% |
| Pre IPO | Post IPO | |
| EPS (₹) | 3.12 | 3.44 |
| P/E (x) | 25.36 | 22.99 |
Object Of The Issue
| Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|
| Funding capital expenditure towards the establishment of the New IVF Centers of the Company. | ₹50.00 |
| Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. | ₹20.00 |
| General corporate purposes. |
Gaudium IVF IPO Peer Comparison
- There is currently no listed company in India operating in the same business segment as the Company.
✅Strengths
- Specialized focus on IVF & women’s healthcare.
- Scalable hub-and-spoke model.
- Experienced promoter-doctors.
- Comprehensive fertility & gynecology services.
- Operates in a growing IVF industry.
⚠️Risks
- High dependence on key doctors.
- Subject to healthcare regulations.
- Competition from IVF chains & clinics.
- Reputation-sensitive business.
- No prior listed track record.
Gaudium IVF IPO Promoter Holding
| Pre Issue Share Holding | 99.98% |
| Post Issue Share Holding | 71.29% |
Gaudium IVF IPO Prospectus
Company Contact Information
| Gaudium IVF Ltd. B1/51, Janak Puri, B-1, New Delhi, 110058 Phone: 011-4885 8585 Email: compliance@gaudiumivfcentre.com Website: https://www.gaudiumivfcentre.com/ |
Gaudium IVF IPO Registrar
| Bigshare Services Pvt. Ltd. Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: https://ipo.bigshareonline.com/IPO_Status.html |
Gaudium IVF IPO Lead Manager(s)
| 1. Sarthi Capital Advisors Private Limited |
Gaudium IVF IPO FAQs
| What is Gaudium IVF IPO? Gaudium IVF IPO is a main-board IPO. The issue is priced at ₹75 to ₹79 per equity share. The IPO is to be listed on the BSE & NSE. |
| When will Gaudium IVF IPO open? The IPO is to open on 20 February 2026 for QIB, NII, and Retail Investors. |
| What is Gaudium IVF IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is Gaudium IVF IPO Size? Gaudium IVF IPO size is ₹165 Crore. |
| What is the Gaudium IVF IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 189 Shares with ₹14,931, while the maximum bid is 2,457 Shares with ₹1,94,103. |
| What is the Gaudium IVF IPO Allotment Date? Gaudium IVF IPO allotment date is 25 February 2026. |
| What is the Gaudium IVF IPO Listing Date? Gaudium IVF IPO listing date is 27 February 2026. The IPO is to be listed on the BSE and the NSE. |
